[go: up one dir, main page]

SE9904129D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE9904129D0
SE9904129D0 SE9904129A SE9904129A SE9904129D0 SE 9904129 D0 SE9904129 D0 SE 9904129D0 SE 9904129 A SE9904129 A SE 9904129A SE 9904129 A SE9904129 A SE 9904129A SE 9904129 D0 SE9904129 D0 SE 9904129D0
Authority
SE
Sweden
Prior art keywords
compounds
novel compounds
triazolo
directed
processes
Prior art date
Application number
SE9904129A
Other languages
English (en)
Inventor
Simon Guile
Brian Springthorpe
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Priority to SE9904129A priority Critical patent/SE9904129D0/sv
Publication of SE9904129D0 publication Critical patent/SE9904129D0/sv
Priority to US10/130,194 priority patent/US6713483B1/en
Priority to JP2001538910A priority patent/JP4859321B2/ja
Priority to DE60003220T priority patent/DE60003220T2/de
Priority to AU14288/01A priority patent/AU1428801A/en
Priority to PCT/SE2000/002229 priority patent/WO2001036421A1/en
Priority to EP00976525A priority patent/EP1232156B1/en
Priority to AT00976525T priority patent/ATE242246T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE9904129A 1999-11-15 1999-11-15 Novel compounds SE9904129D0 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE9904129A SE9904129D0 (sv) 1999-11-15 1999-11-15 Novel compounds
US10/130,194 US6713483B1 (en) 1999-11-15 2000-11-14 [1,2,3]-triazolo[4,5-d] pyrimidine compounds
JP2001538910A JP4859321B2 (ja) 1999-11-15 2000-11-14 新規の［１，２，３］−トリアゾロ［４，５−ｄ］ピリミジン化合物
DE60003220T DE60003220T2 (de) 1999-11-15 2000-11-14 [1,2,3]-TRIAZOLO[4,5-d]PYRIMIDIN-DERIVATE ALS ANTITHROMBOTISCHE MITTEL
AU14288/01A AU1428801A (en) 1999-11-15 2000-11-14 Novel (1,2,3)-triazolo(4,5-D)pyrimidine compounds
PCT/SE2000/002229 WO2001036421A1 (en) 1999-11-15 2000-11-14 Novel [1,2,3]-triazolo[4,5-d]pyrimidine compounds
EP00976525A EP1232156B1 (en) 1999-11-15 2000-11-14 [1,2,3]-TRIAZOLO[4,5-d]PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS
AT00976525T ATE242246T1 (de) 1999-11-15 2000-11-14 (1,2,3)-triazolo(4,5-d)pyrimidin-derivate als antithrombotische mittel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904129A SE9904129D0 (sv) 1999-11-15 1999-11-15 Novel compounds

Publications (1)

Publication Number Publication Date
SE9904129D0 true SE9904129D0 (sv) 1999-11-15

Family

ID=20417726

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9904129A SE9904129D0 (sv) 1999-11-15 1999-11-15 Novel compounds

Country Status (8)

Country Link
US (1) US6713483B1 (sv)
EP (1) EP1232156B1 (sv)
JP (1) JP4859321B2 (sv)
AT (1) ATE242246T1 (sv)
AU (1) AU1428801A (sv)
DE (1) DE60003220T2 (sv)
SE (1) SE9904129D0 (sv)
WO (1) WO2001036421A1 (sv)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0013407D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Forms of a chemical compound
GB0013488D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Chemical compound
US7452870B2 (en) 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
US7115585B2 (en) 2000-08-21 2006-10-03 Inspire Pharmaceuticals, Inc. Compositions for treating epithelial and retinal tissue diseases
US6897201B2 (en) 2000-08-21 2005-05-24 Inspire Pharmaceuticals, Inc. Compositions and methods for the treatment of glaucoma or ocular hypertension
US7018985B1 (en) 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7132408B2 (en) 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7435724B2 (en) 2002-02-27 2008-10-14 Inspire Pharmaceutical, Inc. Degradation-resistant mononucleoside phosphate compounds
EP1598354A1 (en) * 2004-05-18 2005-11-23 Vasopharm Biotech GmbH Compounds containing a N-heteroaryl moiety linked to fused ring moieties for the inhibition of NAD(P)H oxidases and platelet activation
GB0512844D0 (en) * 2005-06-23 2005-08-03 Novartis Ag Organic compounds
WO2007020935A1 (ja) * 2005-08-17 2007-02-22 Ono Pharmaceutical Co., Ltd. Ｐ２ｙ１２受容体および／またはｐ２ｙ１４受容体ブロッカーを含有してなる疼痛治療剤
TWI482772B (zh) * 2006-08-21 2015-05-01 Astrazeneca Ab 適合口服且包含三唑并[4,5-d]嘧啶衍生物之組合物
WO2008054795A2 (en) * 2006-10-31 2008-05-08 Janssen Pharmaceutica, N.V. Triazolopyrimidine derivatives as adp p2y12 receptor antagonists
WO2012063126A2 (en) * 2010-11-09 2012-05-18 Actavis Group Ptc Ehf Improved processes for preparing pure (3ar,4s,6r,6as)-6-amino-2,2-dimethyltetrahdro-3ah-cyclopenta[d] [1,3]-dioxol-4-ol and its key starting material
PL2755957T4 (pl) * 2011-09-14 2017-05-31 Lek Pharmaceuticals D.D. Synteza związków triazolopirymidynowych
EP2570405A1 (en) * 2011-09-14 2013-03-20 LEK Pharmaceuticals d.d. Synthesis of Triazolopyrimidine Compounds
CN102603751A (zh) * 2012-02-24 2012-07-25 中国药科大学 三唑并(4,5-d)嘧啶衍生物及其制备方法与在制药中的用途
WO2014206187A1 (zh) 2013-06-24 2014-12-31 苏州明锐医药科技有限公司 替卡格雷及其中间体的制备方法
WO2014206188A1 (zh) * 2013-06-27 2014-12-31 苏州明锐医药科技有限公司 替格瑞洛的制备方法
CN105272985B (zh) * 2014-06-24 2017-11-21 珠海联邦制药股份有限公司 三唑并[4,5‑d]嘧啶化合物及其合成方法、用途、组合物
CN112915063B (zh) * 2021-01-25 2022-12-20 刘红枚 一种用于治疗子宫平滑肌高频率强直性收缩相关疾病的化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100444123B1 (ko) * 1995-07-11 2004-10-14 아스트라제네카 악티에볼라그 신규한혈소판응집억제제
DE69710490T2 (de) 1996-12-20 2002-10-24 Astrazeneca Ab, Soedertaelje Triazolo(4,5-d)pyrimidinyl-derivate und ihre verwendung als medikamente
SE9702772D0 (sv) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds
SE9702774D0 (sv) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds
TW530058B (en) * 1997-07-22 2003-05-01 Astra Pharma Prod Triazolo [4,5-d]pyrimidine compounos and their use and process for preparation
EP1056749B1 (en) * 1998-02-17 2003-02-19 AstraZeneca UK Limited NOVEL TRIAZOLO(4,5-d)PYRIMIDINE COMPOUNDS
SE9802574D0 (sv) * 1998-07-17 1998-07-17 Astra Pharma Prod Novel compounds
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses

Also Published As

Publication number Publication date
EP1232156A1 (en) 2002-08-21
WO2001036421A1 (en) 2001-05-25
EP1232156B1 (en) 2003-06-04
ATE242246T1 (de) 2003-06-15
DE60003220D1 (de) 2003-07-10
JP2003514819A (ja) 2003-04-22
AU1428801A (en) 2001-05-30
US6713483B1 (en) 2004-03-30
DE60003220T2 (de) 2004-07-15
JP4859321B2 (ja) 2012-01-25

Similar Documents

Publication Publication Date Title
SE9904129D0 (sv) Novel compounds
BG103417A (en) Condensed pyrimidine bicyclic derivatives
UA66801C2 (uk) Триазоло[4,5-d]піримідинові сполуки, спосіб їх одержання (варіанти), фармацевтична композиція на їх основі та спосіб лікування порушень агрегації тромбоцитів
YU45204A (sh) 3-BETA-D-RIBOFURANOZILTIAZOLO/4,5-d/ PIRIMIDINSKI NUKLEOZIDII NJIHOVA UPOTREBA
TR200101567T2 (tr) Yeni triazolo(4.5-D)pirimidin bileşimleri.
UA66825C2 (uk) Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності
SE9701398D0 (sv) Novel compounds
MY148652A (en) New crystalline form of a triazolo(4,5-d)pyrimidine compound
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
EP1334719A3 (en) Pentafluorobenzenesulfonamides and analogs
CA2401229A1 (en) Aryl fused azapolycyclic compounds
MA27769A1 (fr) Dérivées de 2-acylamino-4-phenylthiazole, leur préparation et leur application en thérapeutique
CY1107747T1 (el) Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης
IL127965A0 (en) Pentafluorobenzenesulfonamide derivatives analogs thereof and pharmaceutical compositions containing the same
AP1456A (en) Pharmaceutical agents for the treatment of parkinson's disease, ADHD and microadenomas.
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
SE9804212D0 (sv) Compounds
SE9802574D0 (sv) Novel compounds
SE9902551D0 (sv) Novel compounds
EE200200326A (et) Asendatud homopiperidüülbensimidasooli analoog, meetod selle valmistamiseks ning seda sisaldav farmatseutiline kompositsioon
AU6826700A (en) Ceramide analogs, process for their preparation and their use as antitumor agents
ATE228134T1 (de) Kondensierte pyrimidinderivate und diese enthaltende pharmazeutische zubereitungen
WO2000075158A3 (en) NOVEL 6-PHENYLPURINE 9-β-D-RIBONUCLEOSIDES WITH ANTINEOPLASTIC ACTIVITY, THEIR USE FOR PREPARING PHARMACEUTICAL COMPOSITIONS AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS